ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT”
An Evolution in Name, Structure, and Strategy Reflecting the Company’s AI-Driven Platform and Bio-Native Discovery Vision AUSTIN, Texas–(BUSINESS WIRE)–$IPA... Read more.
Matter Launches Tailored Tech PR Solutions for Fast, Strategic Results
Agency’s project-based PR offerings for B2B tech brands provide flexible program customization to improve visibility and drive on-message media coverage BOSTON–(BUSINESS... Read more.
Rothman Orthopaedics Selects Surgimate to Unify Surgical Scheduling Across Locations
PHILADELPHIA–(BUSINESS WIRE)–Rothman Orthopaedics, a world in leader in the field of orthopedics as well as the largest private musculoskeletal practice... Read more.
Walmart+ Celebrates 5th Anniversary with Expanded Video Streaming Choices
BENTONVILLE, Ark.–(BUSINESS WIRE)–Walmart+ is offering members greater control over their entertainment experience by introducing an enhanced video streaming... Read more.
mRNA Therapeutics Contract Development & Manufacturing Organization Business Research 2025-2030 | Growing Shift Towards Modular and Automated Manufacturing Solutions Promotes Growth and Efficiency – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “mRNA Therapeutics Contract Development & Manufacturing Organization – Global Strategic Business Report”... Read more.
Transcat to Participate in the D.A. Davidson 24th Annual Diversified Industrials & Services Conference on September 18
ROCHESTER, N.Y.–(BUSINESS WIRE)–Transcat, Inc. (NASDAQ: TRNS) (“Transcat” or the “Company”), a leader in test measurement, control and calibration,... Read more.
Ori Biotech’s IRO® Platform Receives FDA Advanced Manufacturing Technology (AMT) Designation
AMT designation provides developers using IRO with earlier and more frequent FDA engagement, accelerating regulatory filings and patient access PHILADELPHIA &... Read more.
Genmab Announces Updated Results from Phase 2 EPCORE® NHL-6 Study Evaluating Epcoritamab Monotherapy in the Outpatient Setting in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
Trial demonstrated the feasibility of treating and monitoring adult patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) in an outpatient... Read more.
CSG Systems International to Hold Third Quarter 2025 Earnings Conference Call on November 5
DENVER–(BUSINESS WIRE)–CSG® (NASDAQ: CSGS) invites you to participate in a conference call on Wednesday, November 5, 2025, at 5:00 p.m. ET to discuss... Read more.
CyberArk Named Leader and Outperformer in GigaOm Radar for Enterprise Password Management
Report underscores CyberArk’s identity security leadership and innovative product capabilities NEWTON, Mass. & PETACH TIKVA, Israel–(BUSINESS WIRE)–CyberArk... Read more.